Proactive Investors - Run By Investors For Investors

It's 'all systems go' as ReNeuron gears up for Phase III stroke disability study

Michael Hunt, CFO at ReNeuron PLC (LON:RENE) sat down with Proactive's Andrew Scott on the day of their results for the year to the end of March 2017 to bring us up to speed on the latest with their therapeutic development programmes.

Meet Alliance Pharma PLC, IXICO PLC, Benchmark Holdings PLC, Clinigen Group PLC and Shield Therapeutics PLC at our event, London , 24 January 2019. Register here »
View full RENE profile View Profile

ReNeuron Group PLC Timeline

December 19 2018

© Proactive Investors 2019

Proactive Investors Limited, trading as “Proactiveinvestors United Kingdom”, is Authorised and regulated by the Financial Conduct Authority.
Registered in England with Company Registration number 05639690. Group VAT registration number 872070825 FCA Registration number 559082. You can contact us here.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use